Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | PLA2G6 | O60733 | 2/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7352473 | 0.83 | FASN (0.43) | FASNSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13677474 | 0.83 | FASN (0.43) | FASNCYP3A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7431888 | 0.82 | FASN (0.47) | FASNCYP3A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7431881 | 0.82 | FASN (0.47) | FASNCYP3A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9740200 | 0.82 | MAOB (0.45) | FASNMAPT | |
| SCHEMBL638641 | 0.82 | MAOB (0.45) | FASNMAPT | |
| SCHEMBL10711852 | 0.82 | FASN (0.47) | FASNCYP3A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28863773 | 0.81 | ALDH1A1 (0.40) | FASNCYP3A4MAPT | |
| SCHEMBL4168233 | 0.77 | TSHR (0.44) | — | |
| SCHEMBL14213794 | 0.76 | CYP3A4 (0.34) | FASNCYP3A4PLA2G6PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10400099-B2 | Halogen-free epoxy resin composition, prepreg, laminate and printed circuit board containing the same | SHENGYI TECHNOLOGY CO., LTD. (CN) | 2019-09-03 | — | — | US | disclosed |
| US-20170298218-A1 | Halogen-Free Epoxy Resin Composition, Prepreg, Laminate and Printed Circuit Board Containing the Same | SHENGYI TECHNOLOGY CO., LTD. (CN) | 2017-10-19 | — | — | US | disclosed |
| US-8729195-B2 | Organosilicon compound, method for producing thereof, and curable silicone composition containing the same | DOW CORNING TORAY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20120309921-A1 | Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same | DOW CORNING TORAY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120309921-A1 | Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same | DOW CORNING TORAY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-8128959-B2 | Polymeric pharmaceutical agent for treatment of cancer and method for production of the same | HIROSHI MAEDA (JP) | 2012-03-06 | — | — | US | disclosed |
| WO-2011081165-A1 | ORGANOSILICON COMPOUND, METHOD FOR PRODUCING THEREOF, AND CURABLE SILICONE COMPOSITION CONTAINING THE SAME | DOW CORNING TORAY CO., LTD. (JP) | 2011-07-07 | — | — | WO | disclosed |
| US-7592311-B2 | Platelet production promoting agent | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2009-09-22 | — | — | US | disclosed |
| US-20090062476-A1 | Polymeric pharmaceutical agent for treatment of cancer and method for production of the same | MAEDA, HIROSHI (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309921-A1 | Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same | SRM, ESD, THEM6 | FASN 262/4885CYP3A4 3627/4885SLC6A2 4132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.